Imperative Care vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Imperative Care is a commercial-stage MedTech company with FDA-cleared Zoom Stroke System used in 78,000+ procedures; raised $100M financing in March 2026 to expand its stroke thrombectomy portfolio and develop the Telos robotic stroke treatment.
About
Imperative Care is a commercial-stage medical technology company focused on advancing treatments for stroke and other thromboembolic diseases — conditions caused by blood clot formation in arteries and veins. Founded and headquartered in Campbell, California, Imperative Care designs and manufactures catheter-based devices for mechanical thrombectomy: the surgical removal of blood clots that cause strokes and other life-threatening vascular events. Its products are engineered to improve access to clots, aspiration performance, and overall procedure efficiency during time-critical stroke interventions.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.